Can-Fite Subsidiary OphthaliX, Announces Completion of Patient Enrollment in Phase II Glaucoma Study for CF101
December 07, 2015 at 07:18 AM EST
OphthaliX Inc. (OTCQB: OPLI), a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic ...
